Not exact matches
The Fraunhofer IME leads the Transnational Access 1 (TNA1) «Cross platform screening and optimization service «and the corresponding
Joint Research Activity (JRA1) «Improved optimization and harmonization of cross-vector screening «both aiming at the provision of comprehensive
range of different well established pro- and eukaryotic expression / production systems to identify the
optimal manufacturing platform for any given vaccine candidate.
The Transnational Access 1 (TNA1) «Cross platform screening and optimization service «and the corresponding
Joint Research Activity (JRA1) «Improved optimization and harmonization of cross-vector screening «will combine the expertise of six different partners (IME, SSI, UOXF, iBET, BPRC and UNISI) to provide the unique offer to test vaccine candidates in a comprehensive
range of different expression hosts, to identify the
optimal production system for further pre-clinical and clinical development.
Joint range of movement is important for
optimal health and avoiding injuries due to muscular tightness.
In contrast to the moment arm findings, this suggests that exercises involving peak contractions at a
range of
joint angles may be
optimal.